120 related articles for article (PubMed ID: 30768270)
1. Targeting the MKK7-JNK (Mitogen-Activated Protein Kinase Kinase 7-c-Jun N-Terminal Kinase) Pathway with Covalent Inhibitors.
Wolle P; Hardick J; Cronin SJF; Engel J; Baumann M; Lategahn J; Penninger JM; Rauh D
J Med Chem; 2019 Mar; 62(5):2843-2848. PubMed ID: 30768270
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Covalent Pyrazolopyrimidine-MKK7 Complexes and a Report on a Unique DFG-in/Leu-in Conformation of Mitogen-Activated Protein Kinase Kinase 7 (MKK7).
Wolle P; Engel J; Smith S; Goebel L; Hennes E; Lategahn J; Rauh D
J Med Chem; 2019 Jun; 62(11):5541-5546. PubMed ID: 31083997
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors.
Noël R; Shin Y; Song X; He Y; Koenig M; Chen W; Ling YY; Lin L; Ruiz CH; LoGrasso P; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2011 May; 21(9):2732-5. PubMed ID: 21185177
[TBL] [Abstract][Full Text] [Related]
4. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.
Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY
Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510
[TBL] [Abstract][Full Text] [Related]
5. Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.
Gong L; Han X; Silva T; Tan YC; Goyal B; Tivitmahaisoon P; Trejo A; Palmer W; Hogg H; Jahagir A; Alam M; Wagner P; Stein K; Filonova L; Loe B; Makra F; Rotstein D; Rapatova L; Dunn J; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Hermann J; Kuglstatter A; Goldstein D
Bioorg Med Chem Lett; 2013 Jun; 23(12):3565-9. PubMed ID: 23664880
[TBL] [Abstract][Full Text] [Related]
6. Covalent Docking Identifies a Potent and Selective MKK7 Inhibitor.
Shraga A; Olshvang E; Davidzohn N; Khoshkenar P; Germain N; Shurrush K; Carvalho S; Avram L; Albeck S; Unger T; Lefker B; Subramanyam C; Hudkins RL; Mitchell A; Shulman Z; Kinoshita T; London N
Cell Chem Biol; 2019 Jan; 26(1):98-108.e5. PubMed ID: 30449673
[TBL] [Abstract][Full Text] [Related]
7. Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities.
Schröder M; Tan L; Wang J; Liang Y; Gray NS; Knapp S; Chaikuad A
Cell Chem Biol; 2020 Oct; 27(10):1285-1295.e4. PubMed ID: 32783966
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.
Song X; Chen W; Lin L; Ruiz CH; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2011 Dec; 21(23):7072-5. PubMed ID: 22004719
[TBL] [Abstract][Full Text] [Related]
9. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.
Fleming Y; Armstrong CG; Morrice N; Paterson A; Goedert M; Cohen P
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):145-54. PubMed ID: 11062067
[TBL] [Abstract][Full Text] [Related]
11. Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies.
Doma A; Kulkarni R; Palakodety R; Sastry GN; Sridhara J; Garlapati A
Bioorg Med Chem; 2014 Nov; 22(21):6209-19. PubMed ID: 25261929
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase.
Tournier C; Whitmarsh AJ; Cavanagh J; Barrett T; Davis RJ
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7337-42. PubMed ID: 9207092
[TBL] [Abstract][Full Text] [Related]
13. Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury.
Vercelli A; Biggi S; Sclip A; Repetto IE; Cimini S; Falleroni F; Tomasi S; Monti R; Tonna N; Morelli F; Grande V; Stravalaci M; Biasini E; Marin O; Bianco F; di Marino D; Borsello T
Cell Death Dis; 2015 Aug; 6(8):e1854. PubMed ID: 26270349
[TBL] [Abstract][Full Text] [Related]
14. Filamin associates with stress signalling kinases MKK7 and MKK4 and regulates JNK activation.
Nakagawa K; Sugahara M; Yamasaki T; Kajiho H; Takahashi S; Hirayama J; Minami Y; Ohta Y; Watanabe T; Hata Y; Katada T; Nishina H
Biochem J; 2010 Mar; 427(2):237-45. PubMed ID: 20156194
[TBL] [Abstract][Full Text] [Related]
15. Discovery of potent and selective covalent inhibitors of JNK.
Zhang T; Inesta-Vaquera F; Niepel M; Zhang J; Ficarro SB; Machleidt T; Xie T; Marto JA; Kim N; Sim T; Laughlin JD; Park H; LoGrasso PV; Patricelli M; Nomanbhoy TK; Sorger PK; Alessi DR; Gray NS
Chem Biol; 2012 Jan; 19(1):140-54. PubMed ID: 22284361
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.
Kamenecka T; Jiang R; Song X; Duckett D; Chen W; Ling YY; Habel J; Laughlin JD; Chambers J; Figuera-Losada M; Cameron MD; Lin L; Ruiz CH; LoGrasso PV
J Med Chem; 2010 Jan; 53(1):419-31. PubMed ID: 19947601
[TBL] [Abstract][Full Text] [Related]
17. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
[TBL] [Abstract][Full Text] [Related]
18. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines.
Tournier C; Dong C; Turner TK; Jones SN; Flavell RA; Davis RJ
Genes Dev; 2001 Jun; 15(11):1419-26. PubMed ID: 11390361
[TBL] [Abstract][Full Text] [Related]
19. Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors.
Dwyer MP; Paruch K; Alvarez C; Doll RJ; Keertikar K; Duca J; Fischmann TO; Hruza A; Madison V; Lees E; Parry D; Seghezzi W; Sgambellone N; Shanahan F; Wiswell D; Guzi TJ
Bioorg Med Chem Lett; 2007 Nov; 17(22):6216-9. PubMed ID: 17904366
[TBL] [Abstract][Full Text] [Related]
20. c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
Gehringer M; Muth F; Koch P; Laufer SA
Expert Opin Ther Pat; 2015; 25(8):849-72. PubMed ID: 25991433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
